Open AccessCost-Effectiveness Analysis of Neoadjuvant Chemotherapy with Intensive Dose of Epirubicin and Different Cycles in Patients with Locally Advanced Breast Cancer: 4 Fe100c Vs. 6 Fe100 C
Author(s) -
Nicolás Ramírez-Torres,
Herrera-Abarca Jorge Eduardo
Publication year - 2013
Publication title -
pharmaceutical regulatory affairs
Language(s) - English
Resource type - Journals
ISSN - 2167-7689
DOI - 10.4172/2167-7689.1000113
Subject(s) - epirubicin , medicine , oncology , chemotherapy , breast cancer , cancer